Particularly noteworthy are the evaluations of GSH concentration, N-formylkynurenine content, and MPO activity in NWS, allowing for high sensitivity and specificity in differentiating patients with NYHA class II and NYHA class III HF. This evidence concerns the gene MPO and hydrops fetalis.